The injection is the third emergency use given in the Gulf country after Sinopharm China and Pfizer / BioNtech.
Bahrain has issued an emergency permit for the use of the coronavirus vaccine by the UK drug company AstraZeneca in collaboration with Oxford University.
The National Health Regulatory Authority (NHRA) approved the vaccine on Monday, according to the Bahrain state news agency.
The agreement was based on an investigation conducted by NHRA in partnership with the clinical review committee and the health ministry’s vaccination committee, the Bahraini News Agency said.
With a population of 1.6 million, the small country has reported more than 99,800 cases and 367 deaths, according to a report from Johns Hopkins University.
The Oxford-AstraZeneca bullet is the third approved in the Gulf country. Bahrain has already been given the green light for its emergency use in a Chinese-made vaccine extracted by Sinopharm, making it the second largest country in the world to Pfizer / BioNtech injection approval.
AstraZeneca, which has vaccine testing has shown a 70.4 per cent effectiveness rate, has come under increasing scrutiny since last week when it informed EU officials that it would cut delivery by 60 per cent. first quarter of the year due to production problems.
The Bahrain News Agency did not report on the amount or timing of vaccine delivery. Photo must be provided in two installments, 28 days apart.